American Association for Cancer Research

Past CBC Leadership and Committees

CBC Chairpersons

William N. Hait, M.D.
Ortho Biotech Oncology Research and Development
Johnson and Johnson Family of Companies
Raritan, NJ

Samir N. Khleif, M.D.
National Cancer Institute
Bethesda, MD

James H. Doroshow, M.D.
National Cancer Institute
Bethesda, MD

Back to top

Assay Validation Committee

Steven I. Gutman, M.D., Lead Co-Chairperson*
Blue Cross and Blue Shield Association
Washington, DC

Peter E. Barker, Ph.D., Co-Chairperson
National Institute of Standards and Technology
Gaithersburg, MD

Nicholas C. Dracopoli, Ph.D., Co-Chairperson*
Centocor, Inc.
Radnor, PA 

Alberto Gutierrez, Ph.D., Co-Chairperson
Food and Drug Administration
Rockville, MD

Steven J. Skates, Ph.D., Co-Chairperson
Massachusetts General Hospital
Boston, MA

M.J. Finley Austin, Ph.D.
Hoffman-La Roche
Nutley, NJ
Joan B. Levy, Ph.D.
Multiple Myeloma Research Foundation
Norwalk, CT
Robert L. Becker, Ph.D.
Food and Drug Administration
Rockville, MD
Elizabeth Mansfield, Ph.D.
Food and Drug Administration
Rockville, MD
Robert C. Bast, Jr., M.D.
UT M. D. Anderson Cancer Center
Houston, TX
Karen M. Maurey
National Cancer Institute
Rockville, MD
Donald A. Berry, Ph.D.
UT M. D. Anderson Cancer Center
Houston, TX
George B. Moseley, III, MBA, JD
Harvard School of Public Health
Boston, MA
Linda A. Bradley, Ph.D.*
Women & Infants Hospital of Rhode  Island
Gray, ME
Richard Naples
Becton, Dickinson and Company
Franklin Lakes, NJ
Peter F. Bross, M.D.
Food and Drug Administration
Rockville, MD
James P. Omel, M.D.
Central Nebraska Multiple Myeloma Support Group
Grand Island, NE
Mark Chang, Ph.D.
Millennium Pharmaceuticals, Inc.
Cambridge, MA
Michael S. Orr, Ph.D.
Food and Drug Administration
Silver Spring, MD
Adam Michael Clark, Ph.D.*
Lance Armstrong Healthcare Foundation     
Austin, TX
Gene A. Pennello, Ph.D.
Food and Drug Administration
Rockville, MD
Viswanath Devanarayan, Ph.D.
Abbott Laboratories
Parsippany, NJ
William J. Pignato
Genentech, Inc.
South San Francisco, CA
Lynn G. Dressler, Dr.PH.
UNC-Chapel Hill
Chapel Hill, NC
David F. Ransohoff, M.D.
UNC-Chapel Hill
Chapel Hill, NC
David B. Endres, Ph.D.
USC-Keck School of Medicine
Los Angeles, CA
Laura H. Reid, Ph.D.*
Conatus Consulting, LLC
Raleigh, NC
Russel K. Enns, Ph.D.
Cepheid
Sunnyvale, CA
Henry Rodriguez, Ph.D., MBA
National Cancer Institute
Bethesda, MD
Fred J. Frullo
Bristol-Myers Squibb Company
Princeton, NJ
Richard L. Schilsky, M.D.
University of Chicago
Chicago, IL
Courtney C. Harper
Food and Drug Administration
Rockville, MD
Robert Schueren
Genentech, Inc.
South San Francisco, CA
Daniel F. Hayes, M.D.
University of Michigan Cancer Center
Ann Arbor, MI
Richard M. Simon, D.Sc.
National Cancer Institute
Bethesda, MD
M. Carolina Hinestrosa, M.A., M.P.H.†
National Breast Cancer Coalition
Washington, DC
Patrick M. Sluss, Ph.D.
Harvard Medical School
Boston, MA
Lois Hinman, Ph.D.
Novartis Pharmaceuticals Corporation
East Hanover, NJ
John J. Sninsky, Ph.D.
Celera Diagnostics
Alameda, CA
Andrew Hruszkewycz, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Sudhir Srivastava, Ph.D.
National Cancer Institute
Rockville, MD
Pearl S. Huang, Ph.D.
Merck & Co.
North Wales, PA
Sheila E. Taube, Ph.D.*
ST – Consulting
Bethesda, MD
J. Milburn Jessup, M.D.
National Cancer Institute
Bethesda, MD
Jeremy M.G. Taylor, Ph.D.
University of Michigan
Ann Arbor, MI
Malik E. Juweid, M.D.
University of Iowa, College of Medicine
Iowa City, IA
Laura J. van ’t Veer, Ph.D.*
The Netherlands Cancer Institute
Amsterdam, Netherlands
Francis Kalush, Ph.D.
Food and Drug Administration
Rockville, MD
Lakshmi Vishnuvajjala, Ph.D.
Food and Drug Administration
Rockville, MD
Karen L. Kaul, M.D., Ph.D.*
NorthShore University HealthSystem
Evanston, IL
Sue-Jane Wang, Ph.D.
Food and Drug Administration
Silver Spring, MD
Gary Kelloff, M.D.
National Cancer Institute
Rockville, MD
Janet A. Warrington, Ph.D.
Affymetrix, Inc.
Santa Clara, CA
George G. Klee, M.D., Ph.D.
Mayo Clinic and Foundation
Rochester, MN
Michael S. Watson, Ph.D., FACMG
American College of Medical Genetics
Bethesda, MD
Walter H. Koch, Ph.D.
Roche Molecular Systems
Pleasanton, CA
Russell S. Weiner, Ph.D.
Bristol-Myers Squibb Company
Lawrenceville, NJ
Steven Lemery, M.D.
Food and Drug Administration
Silver Spring, MD
Judy Yost, M.A., M.T.
Centers for Medicare and Medicaid Services
Baltimore, MD


Back to top

Bioinformatics  Committee

Gunaretnam Rajagopal, Ph.D., Lead Co-Chairperson*
Cancer Institute of New Jersey
New Brunswick, NJ

Kenneth H. Buetow, Ph.D., Co-Chairperson
National Cancer Institute
Bethesda, MD

Weida Tong, Ph.D., Co-Chairperson
FDA's National Center for Toxicological Research
Jefferson, AR

Greg Tucker-Kellogg, Ph.D., Co-Chairperson
Lilly - Singapore Centre for Drug Discovery
Singapore

J. Robert Beck, M.D.
Fox Chase Cancer Center
Philadelphia, PA
Weichung Joe Shih, Ph.D.
Cancer Institute of New Jersey
New Brunswick, NJ
Barbara M. Bryant, Ph.D.*
Constellation Pharmaceuticals
Cambridge, MA
Nathan Siemers, Ph.D.
Bristol-Myers Squibb Company       
Princeton, NJ
Daniel Crichton, M.S.
NASA Jet Propulsion Laboratory
Pasadena, CA
John Speakman
National Cancer Institute
Rockville, MD
Paula Kim
Translating Research Across Communities
Network
Fallbrook, CA
Patty Spears
Patient Advocate
Raleigh, NC
Martin W. McIntosh, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA
Sudhir Srivastava, Ph.D.
National Cancer Institute
Rockville, MD
Timothy O’Leary, M.D., Ph.D.
U.S. Department of Veterans Affairs
Washington, DC
Blaze A. Stancampiano*
Booz Allen Hamilton
Washington, DC
Michael S. Orr, Ph.D.
Food and Drug Administration
Silver Spring, MD
Zhen Zhang, Ph.D.
Johns Hopkins University     
Baltimore, MD 
Joel H. Saltz, M.D., Ph.D.
Ohio State University
Columbus, OH
JoAnne Zujewski, M.D.
National Cancer Institute
Bethesda, MD


 Back to top

Biospecimens Committee

Carolyn Compton, M.D., Ph.D., Lead Co-Chairperson
National Cancer Institute
Bethesda, MD

Brian Holloway, Ph.D., Co-Chairperson
AstraZeneca Pharmaceuticals
Macclesfield, England

Scott Jewell, Ph.D., Co-Chairperson
Ohio State University
Columbus, OH

Elizabeth Mansfield, Ph.D., Co-Chairperson
Food and Drug Administration
Rockville, MD

Kerry L. Blanchard, M.D., Ph.D.
Eli Lilly & Company
Indianapolis, IN 
Irina A. Lubensky, M.D.
National Cancer Institute
Rockville, MD
L. Mark Cosentino, DPM, Ph.D.
SAIC-Frederick, Inc.
Frederick, MD 
Glenn A. Miller, Ph.D.
Genzyme Analytical Services
Westborough, MA
Kerstin A. David, Ph.D.
Indivumed GmbH
Hamburg, Germany
Brian P. Mullaney, M.D., Ph.D.
Eli Lilly & Company
Indianapolis, IN
Maryellen de Mars, Ph.D.
The Critical Path Institute
Rockville, MD
Reena Philip, Ph.D.
Food and Drug Administration
Rockville, MD
Lynn G. Dressler, Dr. P.H.
UNC-Chapel Hill
Chapel Hill, NC
Stephen J. Qualman, M.D.†
Children's Hospital Research Institute
Columbus, OH
Ian M. Fore, Ph.D.
National Cancer Institute
Rockville, MD
Elizabeth M. Rohlfs, Ph.D.
Genzyme Analytical Services
Westborough, MA 
Patricia Goldman
Ovarian Cancer National Alliance          
Washington, DC
Mark E. Sobel, M.D., Ph.D.
American Society for Investigative Pathology
Bethesda, MD
Elizabeth H. Hammond, M.D.
University of Utah School
Salt Lake City, UT
Howard M. Stern, M.D., Ph.D.
Genentech, Inc.
South San Francisco, CA
Richard G. Hegele, M.D., FRCPC, Ph.D.*     
University of Toronto
Toronto, Ontario
Elizabeth A. Thompson*
Susan G. Komen for the Cure
Dallas, TX
Hartmut H. Juhl, M.D., Ph.D.
Indivumed GmbH
Hamburg, Germany
 


Back to top

Information Sharing Committee

George D. Demetri, M.D., Lead Co-Chairperson
Dana-Farber Cancer Institute
Boston, MA

Kapil Dhingra, M.B.B.S., Co-Chairperson*
KAPital Consulting LLC
Sparta, NJ

Gary J. Kelloff, M.D., Co-Chairperson
National Cancer Institute
Rockville, MD

Richard Pazdur, M.D., Co-Chairperson
Food and Drug Administration
Silver Spring, MD

Martin J. Adelman, M.S., J.D.
George Washington University
Washington, DC
Louise Barnett Grochow, M.D.
AstraZeneca Pharmaceuticals
Waltham, MA
Jeffrey Alexander, Ph.D.
Washington CORE LLC
Bethesda, MD
Josephine Johnston, LLB, MBHL        
The Hastings Center
Garrison, NY
J. Carl Barrett, Ph.D.
Novartis Institutes for BioMedical Research
Cambridge, MA
Sara Kenkare-Mitra, Ph.D.
Genentech, Inc.
South San Francisco, CA
David D. Chang, M.D., Ph.D.
Amgen, Inc.
Thousand Oaks, CA
David Pensak, Ph.D.
V.i. Laboratories, Inc.
Wilmington, DE  
John M. Engel, Esq.
Engel & Novitt, LLP
Washington, DC
Dominic G. Spinella, Ph.D.
Pfizer, Inc.
San Diego, CA
Cindy Geoghegan*
Patient and Partners LLC
Wilton, CT
Gillian R. Woollett, M.A., D.Phil.
Engel & Novitt, LLP
Washington, DC
David S. Grayzel, M.D.
Infinity Pharmaceuticals, Inc.
Cambridge, MA
 


Back to top

*During the planning and implementation of the CBC’s work, Dr. Khleif was Special Assistant to the Commissioner at the U.S. Food and Drug Administration, Rockville, MD; Dr. Gutman was at the U.S. Food and Drug Administration, Rockville, MD; Dr. Dracopoli  was at Bristol-Myers Squibb Company, Princeton, NJ; Dr. Bradley was at the Centers for Disease Control and Prevention, Atlanta, GA; Dr. Clark was at the National Cancer Institute, Bethesda, MD; Dr. Kaul was at Northwestern University, Evanston, IL; Dr. Reid was at Expression Analysis, Inc., Durham, NC; Dr. Taube was at the National Cancer Institute, Bethesda, MD; for some of this period, Dr. van’t Veer was on sabbatical at UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Dr. Rajagopal was at the Bioinformatics Institute of Singapore; Dr. Bryant was at Millennium Pharmaceuticals, Cambridge, MA; Mr. Stancampiano was at AstraZeneca Pharmaceuticals, Waltham, MA; Dr. Hegele was at the University of British Columbia, Vancouver, BC; Ms. Thompson was at the Pancreatic Cancer Action Network, El Segundo, CA; Dr. Dhingra was at Hoffmann-La Roche, Inc., Nutley, NJ; Ms. Geoghagen was at the Susan G. Komen Breast Cancer Foundation, Wilton, CT.